Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eclipse: does it live up to its health claims?

J Slade1, Gregory N Connolly, D Lymperis

  • 1School of Public Health, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA.

Tobacco Control
|May 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mental health support across the sight loss pathway: a qualitative exploration of eye care patients, optometrists, and ECLOs.

Eye (London, England)·2023
Same author

Tobacco industry response to a ban on lights descriptors on cigarette packaging and population outcomes.

Tobacco control·2017
Same author

Substantial Equivalence Standards in Tobacco Governance: Statutory Clarity and Regulatory Precedent for the FSPTCA.

Journal of health politics, policy and law·2016
Same author

Can early malignant melanoma be differentiated from atypical melanocytic nevi by in vivo techniques?: Part I. Clinical and dermoscopic characteristics.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
Same author

Authors' response.

Journal of the American Dental Association (1939)·2015
Same author

Electronic cigarettes: the tobacco industry's latest threat to oral health?

Journal of the American Dental Association (1939)·2015

Health claims for RJ Reynolds Tobacco Company's Eclipse smoking article are not supported by evidence. Studies indicate Eclipse may be as toxic as conventional cigarettes, potentially misleading consumers about reduced harm.

Area of Science:

  • Tobacco product analysis
  • Public health
  • Toxicology

Background:

  • RJ Reynolds Tobacco Company (RJR) marketed Eclipse as a novel smoking article potentially reducing health risks.
  • Marketing claims suggested reduced cancer and disease risk compared to conventional cigarettes.

Purpose of the Study:

  • To critically evaluate the plausibility of health claims associated with the Eclipse smoking article.
  • To compare the potential harm of Eclipse to conventional cigarettes.

Main Methods:

  • Analysis of company website data and expert panel reviews.
  • Independent study comparing carcinogen yields of Eclipse, ultralight brands (Now, Carlton), and Premier.
  • Examination of carcinogen levels in Eclipse and Premier over time.

Related Experiment Videos

Main Results:

  • Eclipse aerosol toxin doses are lower per milligram than conventional cigarettes.
  • Per cigarette, Eclipse showed equal or greater toxicity than ultralight brands.
  • Consumer smoking patterns (puff volume, frequency) exceed Federal Trade Commission (FTC) test conditions, potentially altering actual dosing.
  • Eclipse carcinogen yields were higher than Now and similar to Carlton under FTC/International Organization for Standardization (ISO) standards.
  • Carcinogen yields increased over time in Premier and Eclipse versions.
  • Human studies reviewed by RJR lacked evidence from actual Eclipse adopters.

Conclusions:

  • Insufficient evidence exists to support claims that Eclipse is less harmful than conventional cigarettes.
  • Eclipse demonstrates toxicity comparable to or exceeding some commercially available cigarette brands.
  • Consumers may be misled by marketing, necessitating regulatory oversight.